Nex-z is one of two late-stage projects on the go at Intellia, a specialist in CRISPR gene-editing co-founded by Nobel Prize ...

The inaugural TCCI AI-Driven Science Symposium was held in San Francisco from Monday to Tuesday, bringing together three ...

Scientists are nearing a breakthrough in using CRISPR gene-editing to eliminate HIV from human DNA. Early trials of EBT-101 ...

Founded in 2018, Metagenomi is using a Nobel prize-winning approach developed by Jennifer Doudna and Emmanuelle Charpentier ...

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...

It’s become a bit of a tradition for me to recap the Nobel Prizes in my column: In 2023, I covered Claudia Goldin’s work in ...

Connor Tou arrived at University of California, Berkeley, in 2016 with dreams of making biofuel-belching microbes. In his first week, Tou emailed a half-dozen synthetic biology professors about ...

(Reuters) -Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca a license to develop therapies the U.S.-based biotech discover using its AI-driven gene-editing platform, in a deal ...

Christine Du, MBA, CBO & Co-Founder; Chun-Hao Huang, Ph.D., CEO & Co-Founder; Jeff Whitten, Ph.D., Chief Scientific Officer. Photographer: Erin Beach. Under the ...

As the initiative she co-founded celebrates its 10-year anniversary, Chan is pursuing a wildly ambitious goal: unlocking the ...

Editor’s note: Welcome to the weekly edition of The National Observer, which connects the dots on business headlines from across the country to provide actionable business intelligence. Paying members ...